FDA approves Atripla for the treatment of HIV-1 infection in adults (News-Medical-Net)
Bristol-Myers Squibb Company and Gilead Sciences have announced the U.S. Food and Drug Administration (FDA) has granted approval of Atripla (efavirenz 600 mg/ emtricitabine 200 mg/ tenofovir disoproxil fumarate 300 mg) for the treatment of HIV-1 infection in adults.

Once-a-day HIV drug cocktail in one pill wins FDA approval (USA Today)
The federal government on Wednesday approved the first HIV treatment that packs a triple-drug cocktail into a one-a-day pill. Doctors say a bothersome regimen of 20 or 30 tablets will be simplified into one pill taken before bed.

Caraco Pharmaceutical Laboratories, Ltd. Announces FDA Approval to Market Generic Glucotrol(R) (RedNova)
DETROIT, July 12 /PRNewswire-FirstCall/ -- Caraco Pharmaceutical Laboratories, Ltd., announced today that the U.S. Food and Drug Administration (FDA) has granted final approval for the Company's Abbreviated New Drug Application (ANDA) for Glipizide tablets.